TGA Approves Panvax, Avian Flu Vaccine
Unregistered User
If this is not your name, click here.
Contact Us | Order Now | Journals | Bookstore | Register a colleague
 
  SEARCH  
News
Bookstore
Medline
The Web
Meetings & Congresses
Complete Doctor's Guide
 


 EXPLORE :
 news  All News
 webcasts All Webcasts
 All cases All Cases
 Meetings All Meetings & Congresses
 Medical All Medical Resources

top





New drugs / indications

English Dictionary

Medical Dictionary

Thesaurus



Warning | Privacy | Awards



 Favourite Journals 

Click here to choose your favourite journals


 Favourite Sites 

Click here to choose your favourite sites


 Languages 



  




TGA Approves Panvax, Avian Flu Vaccine

MELBOURNE, Australia -- June 17, 2008 -- The Australian Therapeutic Goods Administration (TGA) has approved Panvax, an avian influenza vaccine. Panvax is intended for use in the prevention of influenza caused by a pandemic strain of avian influenza virus.

Three randomised, double-blind clinical studies were conducted in Australia to assess the immunogenicity and/or safety of the vaccine in adults aged 18 to 64 years, and older adults aged 65 years and older. The vaccine, administered as a 2-dose regimen, was found to be safe and well tolerated.

Panvax is a vaccine that can be used only when an influenza pandemic has been officially declared by the Australian Government in consultation with the World Health Organization.

SOURCE: CSL Limited

E-mail this page
to a friend or colleague!
To print,
use this version




Any question regarding a medical diagnosis, treatment, referral, drug availability or pricing should be directed to either a licensed physician or to the product's manufacturer.

If you have any technical questions or other concerns about this site, feel free to contact us at webmaster@docguide.com.

All contents Copyright (c) 1995- Doctor's Guide Publishing Limited. All rights reserved.


Employment opportunities | Partnering opportunities